4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-008780
Chief Discovery Officer sold 20,000 shares at $17.16 ($343,200)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Chief Discovery Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-07 | Sale : show line 1 in the form | −20,000 | $17.16 | $343,200 | 230,056 | D |
| Open-market sales · 20,000 sh · avg $17.16 · $343,200 | ||||||
Loading xslF345X03/form4.xml…